Inventor
PAYAN DONALD
US48 patents
⚠️ This page may combine multiple inventors who share the name “PAYAN DONALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
37 patentsUS7820819B2Oct 26, 2010
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC87 citations99
US7642351B2Jan 5, 2010
2,4-Pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC105 citations99
US7589200B2Sep 15, 2009
5-Fluoro-4N-phenyl-4-pyrimidineamine compounds
RIGEL PHARMACEUTICALS INC102 citations99
US7557210B2Jul 7, 2009
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC190 citations99
US7550460B2Jun 23, 2009
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC95 citations99
US7498435B2Mar 3, 2009
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC93 citations99
US7485724B2Feb 3, 2009
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC119 citations99
US7435814B2Oct 14, 2008
2,4-Pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC94 citations99
US7332484B2Feb 19, 2008
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC146 citations99
US7329672B2Feb 12, 2008
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC130 citations99
US7329671B2Feb 12, 2008
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC147 citations99
US7060827B2Jun 13, 2006
Intermediates useful for making 2,4-pyrimidinediamine compounds
RIGEL PHARMACEUTICALS INC255 citations99
US7034145B2Apr 25, 2006
Directionally cloned random cDNA expression vector libraries, compositions and methods of use
RIGEL PHARMACEUTICALS INC164 citations98
US6455263B2Sep 24, 2002
Small molecule library screening using FACS
RIGEL PHARMACEUTICALS INC117 citations98
US6808906B2Oct 26, 2004
Directionally cloned random cDNA expression vector libraries, compositions and methods of use
RIGEL PHARMACEUTICALS INC63 citations96
US10941134B2Mar 9, 2021
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC18 citations94
US10377742B2Aug 13, 2019
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC20 citations94
US9913842B2Mar 13, 2018
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC8 citations92
US9266856B2Feb 23, 2016
AMPK—activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC14 citations92
US8987303B2Mar 24, 2015
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC16 citations92
US8980921B2Mar 17, 2015
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC16 citations92
US8809370B2Aug 19, 2014
AMPK-activating heterocyclic compounds and methods for using the same
RIGEL PHARMACEUTICALS INC17 citations92
US6316223B1Nov 13, 2001
Mammalian protein interaction cloning system
RIGEL PHARMACEUTICALS INC29 citations92
US6114111ASep 5, 2000
Mammalian protein interaction cloning system
RIGEL PHARMACEUTICALS INC30 citations92
US9878992B2Jan 30, 2018
GDF-8 inhibitors
RIGEL PHARMACEUTICALS INC6 citations84
US6855495B1Feb 15, 2005
Toso as a target for drug screening
RIGEL PHARMACEUTICALS INC6 citations74
US9409884B2Aug 9, 2016
5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them
RIGEL PHARMACEUTICALS INC4 citations70
US6737240B1May 18, 2004
Methods of screening for a multi-drug resistance conferring peptide
RIGEL PHARMACEUTICALS INC7 citations70
US10709703B2Jul 14, 2020
2,4-pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC0 citations63
US6969584B2Nov 29, 2005
Combinatorial enzymatic complexes
RIGEL PHARMACEUTICALS INC5 citations63
US6897031B1May 24, 2005
Multiparameter FACS assays to detect alterations in exocytosis
RIGEL PHARMACEUTICALS INC6 citations62
US10858335B2Dec 8, 2020
2,3-Disubstituted pyridine compounds as TGF-β inhibitors and methods of use
RIGEL PHARMACEUTICALS INC0 citations52
US10233170B2Mar 19, 2019
2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use
RIGEL PHARMACEUTICALS INC0 citations52
US9518040B2Dec 13, 2016
GDF-8 inhibitors
RIGEL PHARMACEUTICALS INC0 citations52
US9511058B2Dec 6, 2016
Methods for using carboxamide, sulfonamide and amine compounds
RIGEL PHARMACEUTICALS INC0 citations52
US6555314B1Apr 29, 2003
Toso as a target for drug screening
RIGEL PHARMACEUTICALS INC1 citations52
US10040766B2Aug 7, 2018
Ubiquitination inhibitors
RIGEL PHARMACEUTICALS INC0 citations37
SINGH RAJINDER
6 patentsUS8835430B2Sep 16, 2014
2,4-pyrimidinediamine compounds and their uses
SINGH RAJINDER48 citations99
US9416112B2Aug 16, 2016
2,4-pyrimidinediamine compounds and their uses
SINGH RAJINDER6 citations92
US9018204B1Apr 28, 2015
2,4-pyrimidinediamine compounds and their uses
SINGH RAJINDER8 citations92
US9346765B2May 24, 2016
2,4-pyrimidinediamine compounds and their uses
SINGH RAJINDER1 citations74
US8993585B2Mar 31, 2015
Cyclic amine substituted pyrimidinediamines as PKC inhibitors
SINGH RAJINDER7 citations72
US10682350B2Jun 16, 2020
2,4-pyrimidinediamine compounds and their uses
SINGH RAJINDER0 citations63